Celligenics Announces China Market Entry, & Signs MOU With West China Hospital

Celligenics is pleased to announce that we have signed a memorandum of understanding with West China Hospital (Hua Xi) of Sichuan University at the 22nd Singapore-Sichuan Trade and Investment Committee Meeting.

We are also pleased to announce that we have selected Chengdu as our headquarters in China, and will be developing an Advanced Therapeutics Development Centre in Chengdu’s High-Tech Industrial Development Zone.

We would like to thank Enterprise (ESG) for their support in our endeavour to build a resilient and competitive global company.

Read More Here: https://www.enterprisesg.gov.sg/media-centre/media-releases/2021/september/mr06621_singapore-and-sichuan-deepen-collaboration-in-trade-and-connectivity-and-innovation

Recent Posts

Mar 21, 2023

Celligenics, NTU, & SRIS Collaborate On New Therapy For Chronic Wounds (Sep 2021)

Celligenics is pleased to announce that we have signed a research collaboration agreement with local research institutes, Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chien School of Medicine (LKCMedicine) and the Skin Research Institute of Singapore (SRIS), under the Skin Innovation Grant (SIG).

Read more

Mar 21, 2023

Celligenics, NTU, & SRIS Collaborate On New Therapy For Chronic Wounds (Sep 2021)

Celligenics is pleased to announce that we have signed a research collaboration agreement with local research institutes, Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chien School of Medicine (LKCMedicine) and the Skin Research Institute of Singapore (SRIS), under the Skin Innovation Grant (SIG).

Read more

Mar 21, 2023

Celligenics, NTU, & SRIS Collaborate On New Therapy For Chronic Wounds (Sep 2021)

Celligenics is pleased to announce that we have signed a research collaboration agreement with local research institutes, Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chien School of Medicine (LKCMedicine) and the Skin Research Institute of Singapore (SRIS), under the Skin Innovation Grant (SIG).

Read more

Mar 21, 2023

Celligenics Unveils Corporate Video Titled Enabling Cellular Therapeutics (May 2021)

Celligenics is pleased to unveil its first corporate video, titled Enabling Cellular Therapeutics. The video introduces our research team and showcases our research facility, reiterating our endeavour to achieve our vision and mission in providing accessible and affordable healthcare solutions for everyone.

Read more

Mar 21, 2023

Celligenics Unveils Corporate Video Titled Enabling Cellular Therapeutics (May 2021)

Celligenics is pleased to unveil its first corporate video, titled Enabling Cellular Therapeutics. The video introduces our research team and showcases our research facility, reiterating our endeavour to achieve our vision and mission in providing accessible and affordable healthcare solutions for everyone.

Read more

Mar 21, 2023

Celligenics Unveils Corporate Video Titled Enabling Cellular Therapeutics (May 2021)

Celligenics is pleased to unveil its first corporate video, titled Enabling Cellular Therapeutics. The video introduces our research team and showcases our research facility, reiterating our endeavour to achieve our vision and mission in providing accessible and affordable healthcare solutions for everyone.

Read more

Mar 21, 2023

Celligenics Signs MOU With Series A Investor Best World International (April 2021)

Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI)

Read more

Mar 21, 2023

Celligenics Signs MOU With Series A Investor Best World International (April 2021)

Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI)

Read more

Mar 21, 2023

Celligenics Signs MOU With Series A Investor Best World International (April 2021)

Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI)

Read more

GET IN TOUCH

Partner With Celligenics

We welcome partnerships to explore new opportunities together at the frontier of regenerative science, across global markets.

Or email us at info@celligenics.com

GET IN TOUCH

Partner With Celligenics

We welcome partnerships to explore new opportunities together at the frontier of regenerative science, across global markets.

Or email us at info@celligenics.com

GET IN TOUCH

Partner With Celligenics

We welcome partnerships to explore new opportunities together at the frontier of regenerative science, across global markets.

Or email us at info@celligenics.com